Histone epigenetic profiling in pharmaco- and toxicoepigenetics.

01 November 2020 → 31 October 2021
Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Epigenetics
    • Posttranslational modifications
  • Medical and health sciences
    • Biomarker discovery
    • Toxicogenomics
Histone epigenetics Mass spectrometry Toxicoepigenetics
Project description

Histone posttranslational modifications have long been recognized to be crucial epigenetic regulators that mediate health, disease and survival. My endpoint goal will be to incorporate the latest in data acquisition and analysis into the toxicoepigenetic mass spectrometry-based assay that is currently under development at the Lab of Pharmaceutical Biotechnology, in order to improve the reliability of the assay report.